Pharmacokinetics of fentanyl intranasal spray when administered via a single-dose versus a multi-dose delivery system in volunteers

Trial Profile

Pharmacokinetics of fentanyl intranasal spray when administered via a single-dose versus a multi-dose delivery system in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Oct 2012

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Cancer pain
  • Focus Pharmacokinetics
  • Sponsors Takeda Pharmaceuticals International GmbH
  • Most Recent Events

    • 02 Oct 2012 New trial record
    • 04 Sep 2012 Primary endpoint 'Peak-drug-concentration' has been met.
    • 04 Sep 2012 Primary endpoint 'Area-under-the-drug-concentration-time-curve' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top